NCT06313892

Brief Summary

The objective of the trial is to assess key areas of uncertainty regarding the use of synchronous home-based tele-exercise in future practice and research, including issues relating to feasibility, safety and potential for efficacy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2024

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2024

Completed
Last Updated

August 31, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

March 10, 2024

Last Update Submit

August 26, 2026

Conditions

Keywords

InactivityTele-exerciseHome-based exerciseHemodialysisFrailtyPhysical function

Outcome Measures

Primary Outcomes (3)

  • Recruitment rate

    Determining recruitment as the number of randomized participants divided by the number of patients assessed for eligibility.

    1 Month

  • Retention rate

    Determining retention rate by the number of randomized participants completing the 12-week follow-up divided by the total number of randomized participants

    12 Weeks

  • Adherence rate

    Adherence will be quantified using two metrics. Overall session persistence will be calculated as the total number of sessions attended, including partially attended sessions, across all intervention participants divided by the total number of scheduled sessions across all intervention participants. Within-session completeness will be calculated as the percentage of prescribed exercises completed per session, excluding preparation time and skipped items.

    12 Weeks

Secondary Outcomes (3)

  • Change in daily physical activity level

    Baseline and 12 Weeks

  • Change in Fried frailty phenotype score

    Baseline and 12 Weeks

  • Change in physical function level

    Baseline and 12 Weeks

Study Arms (2)

Exercise group

EXPERIMENTAL

The participants in the study group will be given an online personalized exercise program at home in non dialysis days. Each session will be 40 to 45 min in duration for 3 days per week over 12 weeks, 36 sessions in total.

Behavioral: Home-based Exercise

Control group

NO INTERVENTION

Participants allocated to the control group will serve as a wait-list usual-care comparator. They will receive their usual nephrological care and will be instructed to maintain their usual treatment regimen and customary dietary and physical activity patterns without structured exercise during the 12-week control period. After study completion, they will be offered access to the same tele-exercise program.

Interventions

The participants in the study group will be given an online personalized exercise program at home in non dialysis days. Synchronous tele-exercise will be delivered using the free teleconference application (app) (Google Meets software). The groups of tele-exercises will be private and the professional will send the link for each training session and will control the access of the participants. Each session will be 40 to 45 min in duration for 3 days per week over 12 weeks, 36 sessions in total.

Exercise group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being Aged 18 years and over
  • Regular in-center HD 3 times a week
  • Completed at least 1 year of stable HD history
  • Without myocardial infarction within past 3 months
  • Permission from their doctors
  • Have decision making capacity to enable them to give informed consent to take part in the study
  • Have access to a smart device (e.g. smart phone, laptop or tablet), and have internet access

You may not qualify if:

  • Unstable cardiac status (angina, decompensated congestive heart failure, severe vascular stenosis, uncontrolled arrhythmias, etc.).
  • Active infection or acute medical illness.
  • Hemodynamic instability.
  • Labile glycemic control.
  • Unstable HD treatment or an ongoing change or titration in the medication regimen.
  • Inability to exercise due to severe mobility limitations, although modifications will be permitted for amputations with prosthesis or seated exercise.
  • Severe musculoskeletal pain at rest or with minimal activity.
  • Inability to sit, stand, or walk unassisted (walking aids such as a cane or walker will be allowed).
  • Shortness of breath at rest or during activities of daily living (NYHA Class IV).
  • Participation in exercise ≥3 times per week addressing ≥2 exercise domains

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Khorshid Dialysis Center

Isfahan, Iran

Location

Related Publications (8)

  • Painter PL, Nelson-Worel JN, Hill MM, Thornbery DR, Shelp WR, Harrington AR, Weinstein AB. Effects of exercise training during hemodialysis. Nephron. 1986;43(2):87-92. doi: 10.1159/000183805.

    PMID: 3713951BACKGROUND
  • Baggetta R, D'Arrigo G, Torino C, ElHafeez SA, Manfredini F, Mallamaci F, Zoccali C, Tripepi G; EXCITE Working group. Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial. BMC Geriatr. 2018 Oct 20;18(1):248. doi: 10.1186/s12877-018-0938-5.

    PMID: 30342464BACKGROUND
  • Hiraki K, Shibagaki Y, Izawa KP, Hotta C, Wakamiya A, Sakurada T, Yasuda T, Kimura K. Effects of home-based exercise on pre-dialysis chronic kidney disease patients: a randomized pilot and feasibility trial. BMC Nephrol. 2017 Jun 17;18(1):198. doi: 10.1186/s12882-017-0613-7.

    PMID: 28623895BACKGROUND
  • Darawad MW, Khalil AA. Jordanian dialysis patients' perceived exercise benefits and barriers: a correlation study. Rehabil Nurs. 2013 Nov-Dec;38(6):315-22. doi: 10.1002/rnj.98. Epub 2013 May 23.

    PMID: 23703743BACKGROUND
  • Rosa CS, Bueno DR, Souza GD, Gobbo LA, Freitas IF Jr, Sakkas GK, Monteiro HL. Factors associated with leisure-time physical activity among patients undergoing hemodialysis. BMC Nephrol. 2015 Nov 27;16:192. doi: 10.1186/s12882-015-0183-5.

    PMID: 26613791BACKGROUND
  • Ortega-Perez de Villar L, Martinez-Olmos FJ, Perez-Dominguez FB, Benavent-Caballer V, Montanez-Aguilera FJ, Mercer T, Segura-Orti E. Comparison of intradialytic versus home-based exercise programs on physical functioning, physical activity level, adherence, and health-related quality of life: pilot study. Sci Rep. 2020 May 19;10(1):8302. doi: 10.1038/s41598-020-64372-y.

    PMID: 32427935BACKGROUND
  • Manfredini F, Mallamaci F, D'Arrigo G, Baggetta R, Bolignano D, Torino C, Lamberti N, Bertoli S, Ciurlino D, Rocca-Rey L, Barilla A, Battaglia Y, Rapana RM, Zuccala A, Bonanno G, Fatuzzo P, Rapisarda F, Rastelli S, Fabrizi F, Messa P, De Paola L, Lombardi L, Cupisti A, Fuiano G, Lucisano G, Summaria C, Felisatti M, Pozzato E, Malagoni AM, Castellino P, Aucella F, Abd ElHafeez S, Provenzano PF, Tripepi G, Catizone L, Zoccali C. Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. J Am Soc Nephrol. 2017 Apr;28(4):1259-1268. doi: 10.1681/ASN.2016030378. Epub 2016 Dec 1.

    PMID: 27909047BACKGROUND
  • Knott S, Hollis A, Jimenez D, Dawson N, Mabbagu E, Beato M. Efficacy of Traditional Physical Therapy Versus Otago-Based Exercise in Fall Prevention for ALF-Residing Older Adults. J Geriatr Phys Ther. 2021 Oct-Dec 01;44(4):210-218. doi: 10.1519/JPT.0000000000000285.

    PMID: 33534336BACKGROUND

MeSH Terms

Conditions

Kidney Failure, ChronicSedentary BehaviorFrailty

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Mohammad Ali Tabibi, Dr

    Pardis Specialized Wellness Institute

    STUDY DIRECTOR
  • Bobby Cheema, Dr

    School of Health Sciences, Western Sydney University, Campbelltow, NSW 2560, Australia

    PRINCIPAL INVESTIGATOR
  • Thomas Wilkinson, Dr

    Diabetes Research Centre, University of Leicester, Leicester, UK

    PRINCIPAL INVESTIGATOR
  • Kenneth Wilund, Dr

    School of Nutritional Sciences and Wellness, Arizona University

    PRINCIPAL INVESTIGATOR
  • Fabio Manferedini, Dr

    Dept of Neuroscience and Rehabilitation, University of Ferrara

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Functional outcomes in both groups will be assessed by an assessor who will be blinded to group allocation. Participants and intervention-delivery staff cannot be blinded because of the nature of the intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly allocate to intervention group or control group and will be examined in the same way.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2024

First Posted

March 15, 2024

Study Start

March 15, 2024

Primary Completion

June 12, 2024

Study Completion

July 2, 2024

Last Updated

August 31, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) that underlie the results reported in the published article, after deidentification are to be shared

Time Frame
The data will be available after the paper is published. No end date.
Access Criteria
Available from the corresponding author upon reasonable request, subject to institutional approval and a data-sharing agreement.

Locations